Literature DB >> 26551031

Treatment of Renal Stones ≥20 mm with Extracorporeal Shock Wave Lithotripsy.

Haihu Wu1, Jianwei Wang, Jiaju Lu, Yuqiu Wang, Zhihong Niu.   

Abstract

AIMS: To identify subgroups of patients with renal stones ≥20 mm that are more suitable for extracorporeal shock wave lithotripsy (ESWL) monotherapy.
METHODS: A total of 376 patients with renal stones ≥20 mm underwent monotherapy with ESWL. The treatment outcome was evaluated after 3 months of follow-up. A stone-free status or fragmentation of stones to 4 mm or smaller was considered efficacious.
RESULTS: At 3 months after treatment, the overall stone-free rate was 64.4%, and the efficacy rate was 70.7%. The efficacy rate was 89.4% for patients with a residual stone surface area ≤50% of baseline after the first ESWL, while the efficacy rate was 32.4% for other patients. The efficacy was 92.2% for stones ≤400 mm2 and those with lower radiodensity, as determined by a plain (KUB) film.
CONCLUSIONS: For renal stones with a surface area ≤400 mm2 and a radiodensity equal to or less than that of the 12th rib as determined by a KUB film, ESWL may be considered the first line of treatment, even for stones with a diameter ≥20 mm. For large stones requiring repeat treatments, the surface area of the residual stones after the first ESWL is a predictor of the final treatment result.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26551031     DOI: 10.1159/000441424

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

1.  Optimal non-invasive treatment of 1-2.5 cm radiolucent renal stones: oral dissolution therapy, shock wave lithotripsy or combined treatment-a randomized controlled trial.

Authors:  Mohammed A Elbaset; Abdelwahab Hashem; Ahmed Eraky; Mohammed A Badawy; Ahmed El-Assmy; Khaled Z Sheir; Ahmed A Shokeir
Journal:  World J Urol       Date:  2019-04-03       Impact factor: 4.226

2.  The "old" 15 mm renal stone size limit for RIRS remains a clinically significant threshold size.

Authors:  Hanan Goldberg; Dor Golomb; Yariv Shtabholtz; Shlomi Tapiero; German Creiderman; Avi Shariv; Jack Baniel; David Lifhshitz
Journal:  World J Urol       Date:  2017-07-29       Impact factor: 4.226

3.  Comparison of three analgesic drug regimens with twelfth subcostal nerve block for pain control during extracorporeal shock wave lithotripsy.

Authors:  Miguel Maldonado-Avila; Leopoldo Mateo Garduño-Arteaga; Roberto Alejandro Vela-Mollinedo; Jorge Jaspersen-Gastelum; Francisco Virgen-Gutierrez; Marcos Del Rosario-Santiago; Victor Rios-Davila
Journal:  Int Urol Nephrol       Date:  2017-11-18       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.